4/A//SEC Filing
Howell Michael 4/A
Accession 0001415889-24-023026
CIK 0001855644other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 5:31 PM ET
Size
6.0 KB
Accession
0001415889-24-023026
Insider Transaction Report
Form 4/AAmended
Zura Bio LtdZURA
Howell Michael
SVP, Translational Medicine
Transactions
- Award
Class A ordinary shares
2024-04-22$3.13/sh+7,987$24,999→ 7,987 total(indirect: By corporation)
Footnotes (3)
- [F1]On April 24, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'A' instead of transaction code 'P'.
- [F2]These shares were acquired in a private placement transaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and Mountaineer Biosciences, Inc. ("Mountaineer") at a purchase price of $3.13 per share.
- [F3]These shares are beneficially owned by Mountaineer. The Reporting Person is the Co-Founder of Mountaineer and, as such, has the power to vote and dispose of the ordinary shares held by Mountaineer. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Zura Bio Ltd
CIK 0001855644
Entity typeother
Related Parties
1- filerCIK 0001970231
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 5:31 PM ET
- Size
- 6.0 KB